A. Robertson et R. Brodersen, EFFECT OF DRUG-COMBINATIONS ON BILIRUBIN-ALBUMIN BINDING, Developmental pharmacology and therapeutics, 17(1-2), 1991, pp. 95-99
Drugs which compete with bilirubin for albumin binding may increase th
e risk of kernicterus. Fortunately, few drugs are strong competitors.
However, in neonatology, many drugs are used simultaneously. We have s
tudied the effect of drug combinations on bilirubin binding using huma
n serum albumin and the peroxidase method. Combinations of aminophylli
ne with phenobarbital, cefotaxime and vancomycin were studied as well
as the combination of vancomycin and cefotaxime. The results show that
the bilirubin-displacing effect of the drug combinations cannot be pr
edicted from each drug's individual effect. These results are consiste
nt with a flexible model of albumin binding. Combinations of drugs whi
ch are both albumin-bound and reach high serum concentrations should b
e tested for their combined effect on bilirubin binding and this infor
mation used in deciding on treatment in sick, premature infants.